CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Open-market sale 10% owner sold 30,830 shares at $16.30 ($502,529)
- 4 Open-market sale Director sold 30,830 shares at $16.30 ($502,529)
- 4 Open-market sale 10% owner sold 88,900 shares at an average $16.96 ($1,507,309)
- 4 Open-market sale Director sold 88,900 shares at an average $16.96 ($1,507,309)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 500,000 shares at $16.80 ($8,400,000)
- 4 Open-market sale 10% owner sold 500,000 shares at $16.80 ($8,400,000)
- 4 Open-market sale 10% owner sold 5,890 shares at $15.90 ($93,666)
- 4 Open-market sale Chief Operating Officer sold 1,000 shares at $20.00 ($20,000)
- 3 Insider Initial Statement of Ownership
- 4 Other disposition 10% owner disposed of 750,000 shares (other)
- 4 Other acquisition Director acquired 1,485 shares (other)
- 4 Other disposition 10% owner disposed of 1,550,271 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Conversion 10% owner acquired 2,649,572 shares (conversion)
- 4 Conversion 10% owner acquired 4,955,316 shares (conversion)
- 4 Conversion Director acquired 4,656,173 shares (conversion)
Page 16 of 18 · 351 filings